DIRECT RELATION OF DNA LESIONS IN MULTIDRUG-RESISTANT HUMAN MYELOMA CELLS TO INTRACELLULAR DOXORUBICIN CONCENTRATION
- 15 November 1988
- journal article
- research article
- Vol. 48 (22) , 6360-6364
Abstract
Using a human myeloma cell line selected for resistance to doxorubicin (8226/DOX), which expresses the multidrug resistance phenotype, we studied the effects of drug accumulation on DNA damage and cytotoxicity in multidrug-resistant cells. The resistant 8226 subline showed a decrease in [14C]doxorubicin accumulation as compared to the sensitive (8226/S) subline at all time points investigated. DNA alkaline elution techniques were used to examine the formation of single and double strand breaks and DNA-protein cross-links following exposure to doxorubicin in both sensitive and resistant sublines. When 8226/S and 8226/DOX40 cells were exposed to the same extracellular concentration of doxorubicin there was a difference in the quantity of DNA lesions occurring, with the 8226/DOX40 line exhibiting less DNA damage. However, when the extracellular concentration of drug was adjusted to yield equivalent intracellular concentrations these differences were removed and both lines exhibited the same degree of damage for all three DNA lesion. The same DNA lesions were also studied in isolated nuclei from sensitive and resistant cells. Such a model removes any confounding factors due to drug accumulation such as altered cytosolic distribution and/or metabolism of drug. We observed no difference in the formation of single or double strand breaks, or DNA-protein cross-links when the nuclei were exposed to the same concentration of doxorubicin. Results from colony-forming assays have shown that when resistant and sensitive 8226 cells were exposed to high concentrations of doxorubicin, there was a good correlation between DNA damage, drug accumulation, and cytotoxicity. This relationship did not hold for lower concentrations of doxorubicin, for which there was a lack of correlation between drug accumulation and cytotoxicity. Such findings may possibly be due to a prolonged retention of drug by the sensitive cell line as compared to the resistant cells. Further studies are under way to examine this possibility.This publication has 21 references indexed in Scilit:
- Identification and characterization of a plasma membrane phosphoprotein which is present in chinese hamster lung cells resistant to adriamycinBiochemical Pharmacology, 1983
- CIRCUMVENTION OF VINCRISTINE AND ADRIAMYCIN RESISTANCE INVITRO AND INVIVO BY CALCIUM INFLUX BLOCKERS1983
- DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.Molecular and Cellular Biology, 1982
- Qualitative and quantitative aspects of intercalator-induced DNA strand breaksBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1979
- DNA-protein crosslinking by trans-platinum(II)diamminedichloride in mammalian cells, a new method of analysisBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1979
- Amino acid-conferred protection against melphalan—Characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cellsBiochemical Pharmacology, 1978
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Modulation of drug permeability in chinese hamster ovary cells. Possible role for phosphorylation of surface glycoproteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1977
- Production of Free Light Chains of Immunoglobulin by a Hematopoietic Cell Line Derived from a Patient with Multiple Myeloma.Experimental Biology and Medicine, 1967
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951